Congenital myasthenic syndrome with glycosylation defect

Congenital myasthenic syndrome with glycosylation defect (CMS-GD) is a rare inherited condition that affects how nerves communicate with muscles. In this disease, the body has trouble adding sugar molecules (called glycans) to important proteins — a process known as glycosylation. When glycosylation does not work properly, the proteins at the junction where nerves meet muscles (called the neuromuscular junction) do not function correctly. This leads to muscle weakness and fatigue that typically begins in infancy or early childhood. Patients with this condition often experience drooping eyelids (ptosis), difficulty with eye movements, weakness in the arms and legs, trouble swallowing or feeding, and breathing difficulties. The muscle weakness tends to get worse with physical activity and may improve with rest, which is a hallmark feature of myasthenic syndromes. Some patients may also have additional features related to the glycosylation defect, such as intellectual disability, seizures, or abnormalities in other organ systems. Treatment is mainly supportive and symptom-based. Some patients respond to medications commonly used in other congenital myasthenic syndromes, such as acetylcholinesterase inhibitors (like pyridostigmine) or other drugs that improve neuromuscular transmission. However, the response to treatment can vary significantly depending on the specific gene involved. Early diagnosis through genetic testing is important because it helps guide the choice of therapy and avoid medications that could worsen symptoms.

Bring these to your next appointment

• Q1.Which specific gene is affected in my child, and what does that mean for treatment options?,Which medications should we try, and which ones should we absolutely avoid?,How often should my child's breathing function be monitored?,What should I do if my child has a sudden worsening of weakness or breathing difficulty?,Are there any clinical trials or new treatments being studied for this condition?,What therapies (physical, occupational, speech) would benefit my child the most?,Should other family members be tested, and what are the chances of having another affected child?

Common questions about Congenital myasthenic syndrome with glycosylation defect